Effects of Concomitant CABG on Outcomes in Veterans Who Require Surgery for Endocarditis
DOI:
https://doi.org/10.59958/hsf.6719Keywords:
coronary artery bypass grafting, CABG, infective endocarditis, Veterans AffairsAbstract
Background: Infective Endocarditis (IE) is a complicated disease frequently accompanied by coronary artery disease (CAD) though no clear guidelines exist for when concomitant revascularization should be undertaken once valve surgery is indicated. Data on this topic within the United States (US) Veteran population, who have unique healthcare needs when compared to the civilian population, is sparse. We investigated the impact of concomitant coronary artery bypass grafting (CABG) on morbidity and mortality in US Veterans requiring surgical management of IE. Methods: We identified 489 patients who underwent surgical management of IE between January 1 2010 and December 31 2020 at any of 43 Veterans Affairs (VA) cardiac surgery centers in the US. Patients were stratified based on who underwent concomitant CABG at the time of operation. Primary outcomes included the occurrence of postoperative myocardial infarction (MI), stroke, or mortality. Continuous variables were compared using independent t-tests or Mann Whitney U tests, and categorical variables were compared using the Chi square test. Cox proportional-hazard models were used to calculate risk for primary outcomes based on group. Results: 61 patients (12.5%) underwent concomitant CABG for CAD. After adjusting for significant covariates, patients who underwent CABG had a higher long-term risk of MI (adjusted hazard ratios (aHR) 2.37, 95% CI: 1.29–4.35, p = 0.005) and higher risk of MI at 30-days (aHR 2.34, 95% CI: 1.06–5.19, p = 0.035). Concomitant CABG was not associated with long-term stroke or death, 30-day stroke or death, or perioperative complications. On sub-analysis of patients with moderate to severe CAD, rates of MI were higher in the CABG group at 30 days (25.9 vs. 3.4%, p = 0.016) and 1 year (33.3 vs. 3.4%, p = 0.004), though not long-term. The mean number of grafts was 1.51 ± 0.76, with only one graft performed in 65.6% (40/61) of patients. Conclusions: Concomitant CABG at the time of operation for IE was associated with increased risk of MI at 30-day and long-term, though most CABGs involved a low number of grafts. It was not associated with 30-day stroke or death, long term stroke or death, or perioperative complications. The optimal treatment of CAD noted during preoperative evaluation for veterans undergoing surgery for IE remains unclear.
References
Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet (London, England). 2012; 379: 965–975.
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European Heart Journal. 2015; 36: 3075–3128.
Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2021; 143: e229.
Alkhouli M, Alqahtani F, Alhajji M, Berzingi CO, Sohail MR. Clinical and Economic Burden of Hospitalizations for Infective Endocarditis in the United States. Mayo Clinic Proceedings. 2020; 95: 858–866.
Sims JR, Anavekar NS, Chandrasekaran K, Steckelberg JM, Wilson WR, Gersh BJ, et al. Utility of cardiac computed tomography scanning in the diagnosis and pre-operative evaluation of patients with infective endocarditis. The International Journal of Cardiovascular Imaging. 2018; 34: 1155–1163.
Thalji NM, Suri RM, Daly RC, Greason KL, Dearani JA, Stulak JM, et al. The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: implications for revascularization in the transcatheter era. The Journal of Thoracic and Cardiovascular Surgery. 2015; 149: 451–460.
Pettersson GB, Hussain ST. Current AATS guidelines on surgical treatment of infective endocarditis. Annals of Cardiothoracic Surgery. 2019; 8: 630–644.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee to Review the Health Effects in Vietnam. Veterans and Agent Orange: Update 11 (2018). 11th edn. National Academies Press: Washington. 2018. Electronic Book.
Clausen AN, Clarke E, Phillips RD, Haswell C, VA Mid-Atlantic MIRECC Workgroup, Morey RA. Combat exposure, posttraumatic stress disorder, and head injuries differentially relate to alterations in cortical thickness in military Veterans. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2020; 45: 491–498.
Sachs-Ericsson N, Joiner TE, Cougle JR, Stanley IH, Sheffler JL. Combat Exposure in Early Adulthood Interacts with Recent Stressors to Predict PTSD in Aging Male Veterans. The Gerontologist. 2016; 56: 82–91.
Agha Z, Lofgren RP, VanRuiswyk JV, Layde PM. Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use. Archives of Internal Medicine. 2000; 160: 3252–3257.
Khuri SF, Daley J, Henderson W, Hur K, Hossain M, Soybel D, et al. Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program. Annals of Surgery. 1999; 230: 414–432.
Massarweh NN, Kaji AH, Itani KMF. Practical Guide to Surgical Data Sets: Veterans Affairs Surgical Quality Improvement Program (VASQIP). JAMA Surgery. 2018; 153: 768–769.
Davis CL, Pierce JR, Henderson W, Spencer CD, Tyler C, Langberg R, et al. Assessment of the reliability of data collected for the Department of Veterans Affairs national surgical quality improvement program. Journal of the American College of Surgeons. 2007; 204: 550–560.
Diab M, Tasar R, Sponholz C, Lehmann T, Pletz MW, Bauer M, et al. Changes in inflammatory and vasoactive mediator profiles during valvular surgery with or without infective endocarditis: A case control pilot study. PloS One. 2020; 15: e0228286.
Diab M, Sponholz C, von Loeffelholz C, Scheffel P, Bauer M, Kortgen A, et al. Impact of perioperative liver dysfunction on in-hospital mortality and long-term survival in infective endocarditis patients. Infection. 2017; 45: 857–866.
Doenst T, Borger MA, Weisel RD, Yau TM, Maganti M, Rao V. Relation between aortic cross-clamp time and mortality–not as straightforward as expected. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2008; 33: 660–665.
Kumar A, Anstey C, Tesar P, Shekar K. Risk Factors for Mortality in Patients Undergoing Cardiothoracic Surgery for Infective Endocarditis. The Annals of Thoracic Surgery. 2019; 108: 1101–1106.
Malmberg M, Gunn J, Sipilä J, Pikkarainen E, Rautava P, Kytö V. Comparison of Long-Term Outcomes of Patients Having Surgical Aortic Valve Replacement With Versus Without Simultaneous Coronary Artery Bypass Grafting. The American Journal of Cardiology. 2020; 125: 964–969.
Diab M, Lehmann T, Weber C, Petrov G, Luehr M, Akhyari P, et al. Role of Concomitant Coronary Artery Bypass Grafting in Valve Surgery for Infective Endocarditis. Journal of Clinical Medicine. 2021; 10: 2867.
Neragi-Miandoab S, Skripochnik E, Michler R, D'Alessandro D. Risk factors predicting the postoperative outcome in 134 patients with active endocarditis. The Heart Surgery Forum. 2014; 17: E35–E41.
Gollmann-Tepeköylü C, Abfalterer H, Pölzl L, Müller L, Grimm M, Holfeld J, et al. Impact of aortic root repair or replacement in severe destructive aortic valve endocarditis with paravalvular abscesses on long-term survival. Interactive Cardiovascular and Thoracic Surgery. 2022; 34: 361–368.
Giraud M, Delahaye F, Berthiller J, Lantelme P, Harbaoui B. Prognosis implication of coronary artery disease in infective endocarditis, the CADIE study. Archives of Cardiovascular Diseases Supplements. 2023; 15: 14–15.
